Cargando…
Correction: Incidence and risk of regorafenib-induced hepatotoxicity
Autores principales: | Zhao, Bin, Zhao, Hong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6349431/ https://www.ncbi.nlm.nih.gov/pubmed/30719219 http://dx.doi.org/10.18632/oncotarget.26576 |
Ejemplares similares
-
Incidence and risk of regorafenib-induced hepatotoxicity
por: Zhao, Bin, et al.
Publicado: (2017) -
Correction: Incidence and risk of hematologic toxicities in cancer patients treated with regorafenib
por: Zhao, Bin, et al.
Publicado: (2019) -
Incidence and risk of hematologic toxicities in cancer patients treated with regorafenib
por: Zhao, Bin, et al.
Publicado: (2017) -
Correction: Effects of regorafenib on the mononuclear/phagocyte system and how these contribute to the inhibition of colorectal tumors in mice
por: Grünewald, Sylvia, et al.
Publicado: (2023) -
Correction: HLA Alleles Influence the Clinical Signature of Amoxicillin-Clavulanate Hepatotoxicity
Publicado: (2014)